Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. (Q50508007)
Jump to navigation
Jump to search
scientific article published on 11 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. |
scientific article published on 11 November 2011 |
Statements
1 reference
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. (English)
1 reference
1 reference
1 reference
1 reference
Lieve Desbonnet
1 reference
Colm M P O'Tuathaigh
1 reference
Claire O'Leary
1 reference
Emilie Petit
1 reference
Niamh Clarke
1 reference
Joseph A Gogos
1 reference
Maria Karayiorgou
1 reference
John L Waddington
1 reference
11 November 2011
1 reference
15
1 reference
9
1 reference
1331-1342
1 reference
Identifiers
1 reference